CF Jumps 24% in the Past 3 Months: What's Driving the Stock?

CF Industries shares rose 24.3% over three months, supported by Q2 2026 net sales rising to $2.22 billion from $1.89 billion and expectations for tight global nitrogen supply through 2027. The company operated at 98% of available ammonia capacity in the first half and expects demand to exceed capacity growth, while Iran-related disruptions removed an estimated 4-4.5 million metric tons of urea and about 1 million tons of ammonia from trade. CF returned capital through $523 million of buybacks since October 2025 and a 20% dividend increase to $0.60 per share, while generating $1.82 billion of trailing-12-month free cash flow.

Analysis

CF’s equity now embeds a meaningful portion of the near-term nitrogen-price recovery, so the relevant question is not whether supply is tight but whether realized ammonia/UAN and urea pricing can remain above marginal European and Middle Eastern production economics into the North American spring application season. Its operating leverage is unusually high because domestic gas costs are structurally advantaged versus European producers; sustained fertilizer pricing converts disproportionately into EBITDA and buyback capacity. This creates a favorable 6-18 month setup versus gas-disadvantaged European nitrogen exposure, but a less compelling outright entry after the recent rerating.

The second-order beneficiary is CVR Partners (UAN), whose smaller float and largely domestic nitrogen exposure can produce greater upside beta if UAN pricing remains firm, although its distribution and operational volatility are materially higher. Conversely, higher nitrogen costs pressure farm economics and can defer acreage/input purchases; seed and crop-input distributors such as Nutrien (NTR) and Mosaic (MOS) may not capture the same margin upside because their earnings are more exposed to volume, potash/phosphate, and retail execution. CF’s capital returns support downside, but buybacks are not incremental earnings growth if commodity prices normalize.

Near-term catalysts are autumn Brazilian buying, India tender activity, and North American prepay/fill data over the next 1-3 months; these will test whether deferred demand is real rather than merely management framing. Thesis failure would be a rapid restoration of Middle East export flows, European plants restarting on lower European gas, or a sustained decline in benchmark nitrogen prices despite low channel inventories. The contrarian view is that geopolitical disruption has already been capitalized while prices have normalized, making CF more vulnerable to a modest pricing miss than headline supply commentary implies.

Key Decisions for Investors

• Do not chase CF outright after the recent rally; establish a 3-6 month long only on a 8-12% pullback or after confirmation that fall ammonia/UAN pricing and order books remain firm. Target a 15-20% upside on renewed 2027 EBITDA revisions; exit if nitrogen benchmarks fall below pre-disruption levels for 4-6 weeks or management cuts volume/price outlook.
• Express the fertilizer-specific thesis as long CF / short NTR in equal dollar amounts for 3-6 months. CF has cleaner exposure to nitrogen pricing and lower gas-cost sensitivity, while NTR carries greater retail-volume and broader nutrient-price risk; reassess if potash prices strengthen materially or North American crop margins improve enough to lift retail demand.
• For higher-risk upside exposure, place UAN on watch rather than initiate immediately; buy only after confirming distribution coverage, plant uptime, and forward UAN pricing. A 20-30% upside is plausible in a sustained tight-nitrogen regime, but position size should be materially below CF given refinery-linked operational concentration and liquidity risk.
• Monitor European TTF gas, Indian urea tenders, Brazilian import pacing, and Middle East export availability weekly. A sharp TTF decline combined with normalized Gulf exports is the trigger to reduce fertilizer longs, as it compresses the marginal-cost support underpinning the sector’s premium valuation.